Status:
RECRUITING
Effect of IMT in Patients After Acute Exacerbations of COPD
Lead Sponsor:
KU Leuven
Collaborating Sponsors:
Hopitaux Iris Sud
Centre Hospitalier Universitaire Saint Pierre
Conditions:
Chronic Obstructive Pulmonary Diseases
COPD
Eligibility:
All Genders
35+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to test whether home-based inspiratory muscle training can reduce hospital readmissions and death in patients recovering from a severe acute exacerbation of chronic ...
Eligibility Criteria
Inclusion
- Patients admitted to the hospital ≥3 days for AECOPD
- Read and speak French, Dutch or English
- Age ≥ 35 years
- Able to provide informed consent
- Possessing a smartphone, compatible with the tele-monitoring app and able to perform video meetings.
Exclusion
- Patients already performing IMT at time of inclusion
- Patients with estimated \<90 days life expectancy
- Non-COPD pulmonary disease as primary diagnosis
- Active malignancy
- Inability to perform IMT or response to questionnaires (e.g., neurological/cognitive impairment)
- Acute instable cardiac arrythmia or ischemia
- Acute pneumothorax
- Planned lung volume reduction procedure \<180days
- Waitlisted for lung transplantation
- Patients admitted to an in-hospital rehabilitation ward
- Patients included in other interventional trial related to COPD that would interfere with our trial outcomes.
Key Trial Info
Start Date :
January 6 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2029
Estimated Enrollment :
358 Patients enrolled
Trial Details
Trial ID
NCT07213128
Start Date
January 6 2026
End Date
February 1 2029
Last Update
January 9 2026
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
AZORG
Aalst, Belgium, 9300
2
Campus Joseph Bracops, Hôpitaux Iris Sud
Anderlecht, Belgium, 1070
3
Centre Hospitalier Universitaire Saint-Pierre
Brussels, Belgium, 1000
4
Grand Hopial de Charleroi
Charleroi, Belgium, 6000